Frontlight ResearchEarly access
Trial site
Huangshi Central Hospital
- 11running trials
- 3closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes4 trials
- Coronary artery disease3 trials
- Chronic kidney disease2 trials
- Stroke2 trials
- Atrial fibrillation1 trial
- Heart failure1 trial
- Hepatitis B1 trial
- Liver and biliary tract cancer1 trial
- Mild cognitive impairment1 trial
- Phase
- Phase 38 trials
- Phase 41 trial
- Status
- Not yet recruiting5 trials
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting2 trials
- Lead sponsor
- Shenzhen HighTide Biopharmaceutical Ltd.3 trials
- Renmin Hospital of Wuhan University2 trials
- Boehringer Ingelheim1 trial
- Capital Medical University1 trial
- First Hospital of China Medical University1 trial
- and 6 more
Running trials
Not yet recruiting
Recruiting
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Methylprednisolone Adjunctive to Endovascular Thrombectomy for Stroke
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease2 recruiting
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
- Hepatitis B1 recruiting
- Liver and biliary tract cancer1 recruiting
- Mild cognitive impairment1 recruiting
- Stroke1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes
Site data: ClinicalTrials.govUpdated 17 Nov 2026